HEADER TRANSFERASE 28-NOV-18 6IB0 TITLE THE STRUCTURE OF MKK7 IN COMPLEX WITH THE COVALENT 4-AMINO- TITLE 2 PYRAZOLOPYRIMIDINE 3A COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 7; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPKK 7,JNK-ACTIVATING KINASE 2,MAPK/ERK KINASE 7,MEK 7, COMPND 5 STRESS-ACTIVATED PROTEIN KINASE KINASE 4,SAPKK4,C-JUN N-TERMINAL COMPND 6 KINASE KINASE 2,JNKK 2; COMPND 7 EC: 2.7.12.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP2K7, JNKK2, MEK7, MKK7, PRKMK7, SKK4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET41B KEYWDS MKK7, INHIBITOR, COVALENT, TRANSFERASE, JNK, KINASE EXPDTA X-RAY DIFFRACTION AUTHOR P.WOLLE,J.HARDICK,M.P.MUELLER,D.RAUH REVDAT 3 24-JAN-24 6IB0 1 REMARK REVDAT 2 27-MAR-19 6IB0 1 JRNL REVDAT 1 27-FEB-19 6IB0 0 JRNL AUTH P.WOLLE,J.HARDICK,S.J.F.CRONIN,J.ENGEL,M.BAUMANN,J.LATEGAHN, JRNL AUTH 2 J.M.PENNINGER,D.RAUH JRNL TITL TARGETING THE MKK7-JNK (MITOGEN-ACTIVATED PROTEIN KINASE JRNL TITL 2 KINASE 7-C-JUN N-TERMINAL KINASE) PATHWAY WITH COVALENT JRNL TITL 3 INHIBITORS. JRNL REF J.MED.CHEM. V. 62 2843 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 30768270 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00102 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 10911 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 764 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.1580 - 4.4450 1.00 2137 161 0.1924 0.2106 REMARK 3 2 4.4450 - 3.5286 1.00 2032 153 0.1988 0.2670 REMARK 3 3 3.5286 - 3.0827 1.00 2001 151 0.2723 0.3449 REMARK 3 4 3.0827 - 2.8009 1.00 2005 150 0.3049 0.3332 REMARK 3 5 2.8009 - 2.6001 1.00 1972 149 0.3042 0.3663 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.170 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2332 REMARK 3 ANGLE : 0.722 3144 REMARK 3 CHIRALITY : 0.042 345 REMARK 3 PLANARITY : 0.005 400 REMARK 3 DIHEDRAL : 7.362 1410 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6IB0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-NOV-18. REMARK 100 THE DEPOSITION ID IS D_1200011460. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10923 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 44.160 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 12.65 REMARK 200 R MERGE (I) : 0.30800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.3900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 13.50 REMARK 200 R MERGE FOR SHELL (I) : 1.23200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.210 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2DYL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM CITRATE, 20 % PEG3350, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.70000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.70000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 107 REMARK 465 GLY A 108 REMARK 465 HIS A 109 REMARK 465 HIS A 110 REMARK 465 HIS A 111 REMARK 465 HIS A 112 REMARK 465 HIS A 113 REMARK 465 HIS A 114 REMARK 465 SER A 115 REMARK 465 ALA A 116 REMARK 465 LEU A 284 REMARK 465 VAL A 285 REMARK 465 ASP A 286 REMARK 465 SER A 287 REMARK 465 LYS A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 THR A 291 REMARK 465 ARG A 292 REMARK 465 SER A 293 REMARK 465 THR A 417 REMARK 465 GLU A 418 REMARK 465 SER A 419 REMARK 465 PRO A 420 REMARK 465 ARG A 421 REMARK 465 THR A 422 REMARK 465 SER A 423 REMARK 465 GLY A 424 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 127 CG CD OE1 NE2 REMARK 470 TYR A 129 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 130 CG CD OE1 NE2 REMARK 470 LYS A 157 CG CD CE NZ REMARK 470 LYS A 173 CG CD CE NZ REMARK 470 GLU A 174 CG CD OE1 OE2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 LYS A 252 CG CD CE NZ REMARK 470 ARG A 283 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 309 CG OD1 OD2 REMARK 470 LYS A 312 CG CD CE NZ REMARK 470 ASP A 314 CG OD1 OD2 REMARK 470 LYS A 342 CG CD CE NZ REMARK 470 GLU A 403 CG CD OE1 OE2 REMARK 470 LYS A 416 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 128 82.01 -162.52 REMARK 500 TYR A 129 176.93 -59.79 REMARK 500 GLN A 130 56.48 -140.39 REMARK 500 MET A 142 74.63 -105.21 REMARK 500 ASP A 259 51.22 -160.78 REMARK 500 ASP A 277 75.57 65.71 REMARK 500 PHE A 278 38.74 -92.89 REMARK 500 LEU A 377 35.91 -89.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue H8Z A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PG4 A 502 DBREF 6IB0 A 117 424 UNP O14733 MP2K7_HUMAN 101 408 SEQADV 6IB0 MET A 107 UNP O14733 INITIATING METHIONINE SEQADV 6IB0 GLY A 108 UNP O14733 EXPRESSION TAG SEQADV 6IB0 HIS A 109 UNP O14733 EXPRESSION TAG SEQADV 6IB0 HIS A 110 UNP O14733 EXPRESSION TAG SEQADV 6IB0 HIS A 111 UNP O14733 EXPRESSION TAG SEQADV 6IB0 HIS A 112 UNP O14733 EXPRESSION TAG SEQADV 6IB0 HIS A 113 UNP O14733 EXPRESSION TAG SEQADV 6IB0 HIS A 114 UNP O14733 EXPRESSION TAG SEQADV 6IB0 SER A 115 UNP O14733 EXPRESSION TAG SEQADV 6IB0 ALA A 116 UNP O14733 EXPRESSION TAG SEQRES 1 A 318 MET GLY HIS HIS HIS HIS HIS HIS SER ALA LYS GLN THR SEQRES 2 A 318 GLY TYR LEU THR ILE GLY GLY GLN ARG TYR GLN ALA GLU SEQRES 3 A 318 ILE ASN ASP LEU GLU ASN LEU GLY GLU MET GLY SER GLY SEQRES 4 A 318 THR CYS GLY GLN VAL TRP LYS MET ARG PHE ARG LYS THR SEQRES 5 A 318 GLY HIS VAL ILE ALA VAL LYS GLN MET ARG ARG SER GLY SEQRES 6 A 318 ASN LYS GLU GLU ASN LYS ARG ILE LEU MET ASP LEU ASP SEQRES 7 A 318 VAL VAL LEU LYS SER HIS ASP CYS PRO TYR ILE VAL GLN SEQRES 8 A 318 CYS PHE GLY THR PHE ILE THR ASN THR ASP VAL PHE ILE SEQRES 9 A 318 ALA MET GLU LEU MET GLY THR CYS ALA GLU LYS LEU LYS SEQRES 10 A 318 LYS ARG MET GLN GLY PRO ILE PRO GLU ARG ILE LEU GLY SEQRES 11 A 318 LYS MET THR VAL ALA ILE VAL LYS ALA LEU TYR TYR LEU SEQRES 12 A 318 LYS GLU LYS HIS GLY VAL ILE HIS ARG ASP VAL LYS PRO SEQRES 13 A 318 SER ASN ILE LEU LEU ASP GLU ARG GLY GLN ILE LYS LEU SEQRES 14 A 318 CYS ASP PHE GLY ILE SER GLY ARG LEU VAL ASP SER LYS SEQRES 15 A 318 ALA LYS THR ARG SER ALA GLY CYS ALA ALA TYR MET ALA SEQRES 16 A 318 PRO GLU ARG ILE ASP PRO PRO ASP PRO THR LYS PRO ASP SEQRES 17 A 318 TYR ASP ILE ARG ALA ASP VAL TRP SER LEU GLY ILE SER SEQRES 18 A 318 LEU VAL GLU LEU ALA THR GLY GLN PHE PRO TYR LYS ASN SEQRES 19 A 318 CYS LYS THR ASP PHE GLU VAL LEU THR LYS VAL LEU GLN SEQRES 20 A 318 GLU GLU PRO PRO LEU LEU PRO GLY HIS MET GLY PHE SER SEQRES 21 A 318 GLY ASP PHE GLN SER PHE VAL LYS ASP CYS LEU THR LYS SEQRES 22 A 318 ASP HIS ARG LYS ARG PRO LYS TYR ASN LYS LEU LEU GLU SEQRES 23 A 318 HIS SER PHE ILE LYS ARG TYR GLU THR LEU GLU VAL ASP SEQRES 24 A 318 VAL ALA SER TRP PHE LYS ASP VAL MET ALA LYS THR GLU SEQRES 25 A 318 SER PRO ARG THR SER GLY HET H8Z A 501 22 HET PG4 A 502 29 HETNAM H8Z 1-[(3~{R})-3-(4-AZANYL-3-ETHYNYL-PYRAZOLO[3,4- HETNAM 2 H8Z D]PYRIMIDIN-1-YL)PIPERIDIN-1-YL]PROP-2-EN-1-ONE HETNAM PG4 TETRAETHYLENE GLYCOL FORMUL 2 H8Z C15 H16 N6 O FORMUL 3 PG4 C8 H18 O5 FORMUL 4 HOH *38(H2 O) HELIX 1 AA1 GLU A 132 ASN A 134 5 3 HELIX 2 AA2 ASN A 172 SER A 189 1 18 HELIX 3 AA3 ALA A 219 GLN A 227 1 9 HELIX 4 AA4 PRO A 231 GLY A 254 1 24 HELIX 5 AA5 LYS A 261 SER A 263 5 3 HELIX 6 AA6 CYS A 296 MET A 300 5 5 HELIX 7 AA7 ALA A 301 ASP A 306 1 6 HELIX 8 AA8 ARG A 318 GLY A 334 1 17 HELIX 9 AA9 THR A 343 GLU A 354 1 12 HELIX 10 AB1 SER A 366 LEU A 377 1 12 HELIX 11 AB2 LYS A 386 LEU A 391 1 6 HELIX 12 AB3 HIS A 393 LEU A 402 1 10 HELIX 13 AB4 ASP A 405 LYS A 416 1 12 SHEET 1 AA1 5 LEU A 136 GLU A 141 0 SHEET 2 AA1 5 GLN A 149 PHE A 155 -1 O ARG A 154 N GLU A 137 SHEET 3 AA1 5 VAL A 161 ARG A 168 -1 O ILE A 162 N MET A 153 SHEET 4 AA1 5 ASP A 207 MET A 212 -1 O MET A 212 N ALA A 163 SHEET 5 AA1 5 CYS A 198 ILE A 203 -1 N GLY A 200 O ALA A 211 SHEET 1 AA2 3 THR A 217 CYS A 218 0 SHEET 2 AA2 3 ILE A 265 LEU A 267 -1 O LEU A 267 N THR A 217 SHEET 3 AA2 3 ILE A 273 LEU A 275 -1 O LYS A 274 N LEU A 266 LINK SG CYS A 218 CAV H8Z A 501 1555 1555 1.60 SITE 1 AC1 7 MET A 142 VAL A 196 GLU A 213 MET A 215 SITE 2 AC1 7 CYS A 218 LYS A 221 LEU A 266 SITE 1 AC2 7 LEU A 139 GLU A 141 MET A 142 LYS A 152 SITE 2 AC2 7 HIS A 362 MET A 363 HOH A 613 CRYST1 59.400 66.000 86.400 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016835 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015152 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011574 0.00000